HiberCell is a clinical stage oncology company, dedicated to the advancement of first-in-class agents with the novel MOA of modulation of adaptive stress pathways and anti-tumor immunity. We believe that therapeutic modulation of these mechanisms allows us to address tumor metastasis, treatment resistance, and cancer relapse; all significant drivers of cancer-related deaths. Our product candidates HC-5404 and HC-7366, both completing Phase 1a clinical trials, target the stress response kinases PERK and GCN2, respectively, while our product candidate odetiglucan, currently in Phase 2 clinical development, modulates the anti-tumor innate immune response.
View Top Employees from HiberCell| Website | https://www.hibercell.com/ |
| Employees | 45 (45 on RocketReach) |
| Founded | 2019 |
| Address | 619 West 54th Street 8th Floor, New York, New York 10019, US |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering |
Looking for a particular HiberCell employee's phone or email?
HiberCell Questions
45 people are employed at HiberCell.
HiberCell is based in New York, New York.
Top HiberCell Employees
-
31
-
View
Nandita Bose
Senior VIce President, Clinical and Translational Medicine at HiberCell
Minneapolis, MN, US24 -
55+
-
View
Michele Gargano
Vice President Clinical Operations and Program Management at HiberCell
Rockville, MD, US53 -
11
-
11
-
44
-
25
-
41
-
15+
Related Companies
